A pediatric case of dermatofibrosarcoma protuberans: an immunohistochemical study
Related Experiment Video
Updated: Oct 17, 2026
Murine Dermal Fibroblast Isolation by FACS
Published on: January 7, 2016
A Patrizi1, F Vespignani, G O Fraternali
1Department of Clinical and Experimental Medicine, University of Study of Bologna, Italy.
Abstract:
Dermatofibrosarcoma protuberans (DFSP) is a fibrohistiocytic tumor of intermediate malignancy that usually occurs in early or mid-adult life as a nodular cutaneous mass. DFSP has rarely been reported during childhood or at birth. We report a case of childhood DFSP that illustrates the usefulness of immunohistochemical analysis in the differential diagnosis between DFSP and other fibrohistiocytic proliferations occurring in the skin. A prompt and correct diagnosis is very important in order to ensure appropriate treatment and to prevent local recurrences.
Insights
Dermatofibrosarcoma protuberans (DFSP) is a rare skin tumor in children. Immunohistochemistry aids in diagnosing childhood DFSP, distinguishing it from other skin growths for proper treatment.
Area of Science:
- Oncology
- Dermatopathology
- Pediatric Oncology
Background:
- Dermatofibrosarcoma protuberans (DFSP) is an intermediate-grade fibrohistiocytic tumor typically presenting as a cutaneous nodule in adults.
- DFSP is exceptionally rare in pediatric populations, with limited documented cases in children or at birth.
Observation:
- This report details a case of DFSP occurring in a child.
- The case highlights the diagnostic challenges in differentiating pediatric DFSP from other fibrohistiocytic skin proliferations.
Findings:
- Immunohistochemical analysis proved crucial in establishing the correct diagnosis of DFSP in the pediatric case.
- Specific immunohistochemical markers were instrumental in distinguishing DFSP from other similar skin lesions.
Implications:
- Accurate and timely diagnosis of pediatric DFSP is essential for effective management.
- Early diagnosis can prevent local recurrence and ensure appropriate therapeutic strategies are implemented for childhood DFSP.
